Case studies

Working with our customers to reduce time to market, deliver on quality, provide deep therapeutic expertise, and enhance R&D ROI.

Highlights

We focus our innovation on the factors that matter most — accelerating time to market, reducing costs and enhancing quality. Learn more about how we've helped clients meet and exceed their goals in this selected library of case studies.

By taking a site and patient-centric approach, and leveraging advanced tools and real-time data insights, we maximise patient access, recruitment, and retention—ensuring that every trial is conducted with efficiency, agility, and a commitment to improving patient outcomes.

All case studies

Filter our case studies by categories, selecting amongst our broad range of solutions.

Phase 3 in primary immune thrombocytopenia

ICON was approached by a drug development sponsor to conduct a global, phase 3 trial in an adult patients with primary immune thrombocytopenia. The trial was part of a four-program study with challenging recruitment timelines.
Read more

Hybrid clinical trial model in a Lupus Nephritis study

The sponsor contracted ICON to conduct a randomised trial using a traditional site-based approach to identify the target dose and investigate the safety, tolerability and efficacy of three doses of an investigative compound administered subcutaneously for the treatment of lupus nephritis.
Read more

Rapid post-market study start-up

The MDDR team developed a study protocol and start-up plan that enabled execution several months faster than a typical study. The team also transitioned from a PMA study to a PAS study.
Read more

Overcoming challenges and exceeding recruitment timeline

ICON was awarded a study in an adult patient population with Fibrodysplasia Ossificans Progressiva (FOP), an ultra-rare indication. Despite complex study logistics ICON’s proactive site and patient support strategy enabled recruitment to be completed ahead of schedule.
Read more

Achondroplasia

The client was conducting a a pharmaco-epidemiologic study to characterise the impacts and burden of Achondroplasia across the lifespan.
Read more

Solutions case studies

Our solutions span the entire lifecycle of product development and can be adapted to suit small local trials or large global programs. Explore our work in the different aspects of our solutions.

Let's collaborate

Discover how ICON's expertise transforms clinical trials.